Drug distributor McKesson missed estimates for third-quarter revenue on Wednesday, hurt by less-than-expected sales in its ...

Healthcare distributor and services company McKesson (NYSE:MCK) fell short of the market’s revenue expectations in Q4 CY2024, ...

McKesson (NYSE: MCK) Q3 2025 Earnings Call Feb 05, 2025, 4:30 p.m. ET Please stand by. Welcome to McKesson's third quarter ...

Irving-based McKesson (NYSE: MCK) announced on Feb. 4 an agreement to buy an 80% controlling interest in New Providence, New ...

Shares of McKesson Corp. MCK slipped 1.63% to $594.75 Friday, on what proved to be an all-around rough trading session for ...

Q3 2025 Earnings Call Transcript February 5, 2025 Operator: Welcome to McKesson’s Third Quarter Fiscal 2025 Earnings ...

Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors ...

McKesson (MCK) and AmerisourceBergen (ABC) are among the pharmaceutical wholesalers that have won a bid to dismiss antitrust allegations that ...

Welcome to McKesson's Third Quarter Fiscal 2025 Earnings Conference Call. Please be advised that today's conference is being recorded. At this time, I'd like to turn the conference over to Rachel ...

Baird raised the firm’s price target on McKesson (MCK) to $729 from $693 and keeps an Outperform rating on the shares. The firm said they are ...

With a positive outlook, McKesson raised its fiscal 2025 adjusted EPS guidance to a range of $32.55 to $32.95, indicating ...

McKesson inked a deal to buy a controlling interest in Prism Vision Holdings, as it also logged higher profit and revenue in its fiscal third quarter. The drug distributor said Wednesday that it ...